Vernonia amygdalina leaf extract protects against carbon tetrachloride-induced hepatotoxicity and nephrotoxicity: a possible potential in the management of liver and kidney diseases

Abstract views: 478 / PDF downloads: 363




Vernonia amygdalina, Rat, Kidney, Liver, Heart, Carbon tetrachloride


The rising prevalence of liver and kidney diseases is worrisome and constitutes a major threat to public health. The present study investigates the medicinal potentials of Vernonia amygdalina leaves in the management of liver and kidney diseases. Albino rats were randomly divided into five groups each containing 5 animals. In all groups, except group I (control), animals were exposed to 3 ml/kg bw of CCl4 and then administered further different treatments. Groups III, IV, and V each were treated with 50 mg/kg bw, 100 mg/kg bw of bitter leaf extract, and 100 mg/kg bw of silymarin, respectively. Group II animals were left untreated after exposure to toxicant. Activities of creatine kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), as well as the level of urea, uric acid, and bilirubin were determined in the serum and tissue homogenates. Lipid profile as well as activities of superoxide dismutase (SOD) and catalase (CAT) were also determined. Exposure to CCl4 resulted in a significant increase in CK, AST, ALP, and ALT levels as well as bilirubin, urea, and uric acid when compared to the control. Lipid profile was disrupted, activities of SOD and CAT were markedly inhibited and the level of GSH was significantly depleted. However, treatment with V. amygdalina reversed the toxic trend in a dose-dependent manner comparable to animals treated with silymarin. In conclusion, V. amygdalina leaf extract restored deranged lipid profile, distorted histoarchitecture as well as liver and kidney function markers. Hence, the plant is a potential candidate for the management of liver and kidney diseases.


Abdulmalik, O., Oladapo, O. O., & Bolaji, M. O. (2016). Effect of aqueous extract of Vernonia amygdalina on atherosclerosis in rabbits. ARYA Atherosclerosis, 12(1), 35-40.

Adesanoye, O. A., & Farombi, E. O. (2010). Hepatoprotective effects of Vernonia amygdalina (Astereaceae) in rats treated with carbon tetrachloride. Experimental and Toxicologic Pathology, 62(2), 197-206.

Anibijuwon, I. I., Oladejo, B. O., Adetitun, D. O., & Kolawole, O. M. (2012). Antimicrobial activities of Vernonia amygdalina against oral microbes. Global Journal of Pharmacology, 6(3), 178-185.

Beutler, E. (1963). Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine, 61, 882-888.

Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., & Tsioufis, K. P. (2020). Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. European Journal of Internal Medicine, 80, 1-11.

Clement, E., Erharuyi, O., Vincent, I., Joy, A., Christopher, A., Anthony, A., & Abiodun, F. (2014). Significance of bitter leaf (Vernonia amagdalina) in tropical diseases and beyond: a review. Malaria Chemotherapy Control & Elimination, 3(120), 1-10.

Ebuehi, O. A., & Ajagun-Ogunleye, M. O. (2017). Neurochemical impact of the aqueous extract of Vernonia amygdalina and Talinum triangulare on learning and memory in male Wistar rats. International Journal of Brain and Cognitive Sciences, 6(5), 81-88.

Englehardt, A. (1970). Measurement of alkaline phosphatase. Aerztl Labor, 16(42), 1.

Farombi, E. O., & Owoeye, O. (2011). Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. International Journal of Environmental Research and Public Health, 8(6), 2533-2555.

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of their preparative ultracentrifuge. Clinical Chemistry, 18, 499–502.

Grove, T. H. (1979). Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clinical Chemistry, 25(4), 560-564.

Gurib-Fakim, A. (2006). Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular Aspects of Medicine, 27(1), 1-93.

Hamburger, M., & Hostettmann, K. (1991). 7. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry, 30(12), 3864-3874.

Jan Mohamed, H. J. B., Yap, R. W. K., Loy, S. L., Norris, S. A., Biesma, R., & Aagaard-Hansen, J. (2015). Prevalence and determinants of overweight, obesity, and type 2 diabetes mellitus in adults in Malaysia. Asia Pacific Journal of Public Health, 27(2), 123-135.

Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., & Biryukov, S. (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1603-1658.

Khafar, K. R., & Kakey, E. S. (2020). Hepatorenal Function Markers Alteration in Aged and Aged Related Disease in Human. Indian Journal of Public Health Research & Development, 11(5), 844–849.

Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J. A., Fogo, A. B., & Yang, C. W. (2017). Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. The Lancet, 390(10105), 1888-1917.

Marcellin, P., & Kutala, B. K. (2018). Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening. Liver International, 38, 2-6.

Misra, H. P., & Fridovich, I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry, 247(10), 3170-3175.

Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., & Naghavi, M. (2014). Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine, 12(1), 145.

Nandi, A., Yan, L. J., Jana, C. K., & Das, N. (2019). Role of catalase in oxidative stress-and age-associated degenerative diseases. Oxidative Medicine and Cellular Longevity, 2019, 9613090.

Rastogi, R. P., & Mehrotra, B. N. (1990). Compendium of Indian medicinal plants, vol. 1. CSIR, New Delhi, 118-122.

Reitman, S., & Frankel, S. (1957). Glutamic–pyruvate transaminase assay by colorimetric method. American Journal of Clinical Pathology, 28(1), 56-63.

Singh, P., & Singhi, C. L. (1981). Chemical investigation of clerodendron-fragrans. Journal of the Indian Chemical Society, 58(6), 626-627.

Sinha, A. K. (1972). Colorimetric assay of catalase. Analytical Biochemistry, 47(2), 389-394.

Stepanova, M., De Avila, L., Afendy, M., Younossi, I., Pham, H., Cable, R., & Younossi, Z. M. (2017). Direct and indirect economic burden of chronic liver disease in the United States. Clinical Gastroenterology and Hepatology, 15(5), 759-766.

Tietz, N. W. (1995). Clinical guide to laboratory tests. In Clinical guide to laboratory tests (pp. 1096-1096), 3rd ed. Philadelphia: Saunders and Co. Publishers.

Trinder, P. (1969). A simple Turbidimetric method for the determination of serum cholesterol. Annals of Clinical Biochemistry, 6(5), 165-166.

Udem, S. C., Obidoa, O., & Asuzu, I. U. (2010). Acute and chronic toxicity studies of Erythrina senegalensis DC stem bark extract in mice. Comparative Clinical Pathology, 19(3), 275-282.

Ugwu Okechukwu, P. C., Nwodo Okwesili, F. C., Joshua Parker, E., Odo Christian, E., & Ossai Emmanuel, C. (2013). Effect of ethanol leaf extract of Moringa oleifera on lipid profile of mice. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 4(1), 1324-1332.

Vanderlinde, R. E. (1981). Urinary enzyme measurements in the diagnosis of renal disorders. Annals of Clinical & Laboratory Science, 11(3), 189-201.

Weichselbaum, C. T. (1946). An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. American Journal of Clinical Pathology, 16(3), 40-49.

Whitby, L. G., Percy-Robb, I. W., & Smith, A. F. (1984). Enzymes test in diagnosis. Lecture Notes on Clinical Chemistry, 3rd ed., Blackwell Sci. Publication, London, pp. 138–168.

Wong, F. C., Woo, C. C., Hsu, A., & Tan, B. K. H. (2013). The anti-cancer activities of Vernonia amygdalina extract in human breast cancer cell lines are mediated through caspase-dependent and p53-independent pathways. PLOS ONE, 8(10), e78021.

Xiong, Q., Liu, J., & Xu, Y. (2019). Effects of uric acid on diabetes mellitus and its chronic complications. International Journal of Endocrinology, 2019, 9691345.

Zhang, L. B., & Feng, M. G. (2018). Antioxidant enzymes and their contributions to biological control potential of fungal insect pathogens. Applied Microbiology and Biotechnology, 102(12), 4995-5004.




How to Cite

Ogunmoyole, T., Apanisile, Y. B., Adewale Akeem, Y., & Makun, O. J. (2022). Vernonia amygdalina leaf extract protects against carbon tetrachloride-induced hepatotoxicity and nephrotoxicity: a possible potential in the management of liver and kidney diseases. International Journal of Plant Based Pharmaceuticals, 3(1), 1–9.



Research Articles
Received 2022-07-08
Accepted 2022-09-26
Published 2022-09-30